Skip to content
healthcare.dev

Doxazosin

NDC 71610-153, Doxazosin, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-153
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075580
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-153 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
71610-153-607161001536090 TABLET in 1 BOTTLE (71610-153-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f1dc70f6-4329-46da-8990-7bd6eec9d37d

Use it

Look up 71610-153 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-153 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-153. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.